Remdesivir, Molnupiravir and Nirmatrelvir remain active against SARS-CoV-2 Omicron and other variants of concern
Sign Up to like & getrecommendations! Published in 2022 at "Antiviral Research"
DOI: 10.1016/j.antiviral.2022.105252
Abstract: We assessed the in vitro antiviral activity of remdesivir and its parent nucleoside GS-441524, molnupiravir and its parent nucleoside EIDD-1931 and the viral protease inhibitor nirmatrelvir against the ancestral SARS-CoV2 strain and the five variants… read more here.
Keywords: concern; molnupiravir nirmatrelvir; nirmatrelvir remain; variants concern ... See more keywords